Basics
Even before final studies on positive health care effects are available, the Federal Institute for Drugs and Medical Devices gives you the option of billing DiGAs through statutory health insurance. The pricing is left to the manufacturers themselves in the first accounting year. This “fast-track” procedure enables an early entry into digital care in the health sector, which will be expanded to an increased extent by digital offers in the future. This offers a wide range of opportunities for manufacturers to introduce their products.
